Rick Doblin, PhD, is one of the most influential voices in the modern psychedelic movement. As the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), Rick has spent more than 35 years leading the global conversation around the responsible and ethical use of psychedelic medicines. His work has been instrumental in advancing clinical research, shaping public policy, and restoring scientific legitimacy to therapies that address trauma, depression, and end-of-life anxiety.

Through his tireless advocacy and deep-rooted compassion, Rick has helped build the foundation upon which today’s psychedelic-assisted therapy practices stand. From securing FDA breakthroughs for MDMA-assisted psychotherapy to championing frameworks that prioritize safety, access, and cultural integrity, his contributions have profoundly influenced how healing is approached across the mental health landscape.

Rick’s presence as an advisor to Mystic Health is both an honor and a meaningful affirmation of our shared vision. His enduring commitment to human-centered healing continues to inspire our work at every level—from research design and ethics to community outreach and integrative care.

The entire team at Mystic Health is deeply grateful to have Rick Doblin on this journey with us.